富士フイルムバイオテクノロジーズは、生物製剤製造における最も困難な問題の一つを解決する精密精製技術として機能するShunzymeXを発表しました。この発表会は、バイオ医薬品の製造において最も困難な問題の一つを解決する精密精製技術として機能します。
Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, announced…
Parse Biosciences, the leading provider of accessible and scalable single cell sequencing…
Veeva Systems announced that Boehringer Ingelheim has launched its own drug discovery…
Astellas Pharma and YASKAWA Electric have agreed to form a joint venture.…
Agatica Inc., which promotes cashless medical care, is pleased to announce that…
JiMED Inc., a developer of wireless implantable BMI system medical devices, has…
Boston Medical Sciences Co., Ltd. is pleased to announce that it has…
PHC Corporation has signed a Master Collaboration Agreement with CCRM to work…
アカウントにサインインする